These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3967781)

  • 1. The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women.
    Lobo RA; Shoupe D; Serafini P; Brinton D; Horton R
    Fertil Steril; 1985 Feb; 43(2):200-5. PubMed ID: 3967781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome.
    Matteri RK; Stanczyk FZ; Gentzschein EE; Delgado C; Lobo RA
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1704-9. PubMed ID: 2532471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
    Wong IL; Morris RS; Chang L; Spahn MA; Stanczyk FZ; Lobo RA
    J Clin Endocrinol Metab; 1995 Jan; 80(1):233-8. PubMed ID: 7829618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women.
    Fruzzetti F; de Lorenzo D; Parrini D; Ricci C
    J Clin Endocrinol Metab; 1994 Sep; 79(3):831-5. PubMed ID: 8077369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum androstanediol glucuronide in women with facial hirsutism.
    Salman K; Spielvogel RL; Shulman LH; Miller JL; Vanderlinde RE; Rose LI
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):411-4. PubMed ID: 1564146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of endogenous progesterone on serum levels of 5 alpha-reduced androgens in hirsute women.
    Dewis P; Newman M; Anderson DC
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):383-92. PubMed ID: 6542470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of plasma androstanediol glucuronide measurements in women with idiopathic hirsutism.
    Kirschner MA; Samojlik E; Szmal E
    J Clin Endocrinol Metab; 1987 Oct; 65(4):597-601. PubMed ID: 3654909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of spironolactone on adrenal steroidogenesis in hirsute women.
    Serafini P; Lobo RA
    Fertil Steril; 1985 Nov; 44(5):595-9. PubMed ID: 2996951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
    Lobo RA; Goebelsmann U; Horton R
    J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of spironolactone on hair shaft diameter in hirsute females.
    McLellan AR; Rentoul J; MacKie R; McInnes GT
    Postgrad Med J; 1989 Jul; 65(765):459-62. PubMed ID: 2690044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel use of spironolactone: treatment of hirsutism.
    Shapiro G; Evron S
    J Clin Endocrinol Metab; 1980 Sep; 51(3):429-32. PubMed ID: 7410528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin).
    Andreyko JL; Monroe SE; Jaffe RB
    J Clin Endocrinol Metab; 1986 Oct; 63(4):854-9. PubMed ID: 2943756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of spironolactone on hirsutism and female androgen metabolism.
    Dorrington-Ward P; McCartney AC; Holland S; Scully J; Carter G; Alaghband-Zadeh J; Wise P
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):161-7. PubMed ID: 4053414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone in the treatment of hirsutism.
    Anttila L; Ruutiainen K; Erkkola R
    Ann Chir Gynaecol Suppl; 1987; 202():32-4. PubMed ID: 3310825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women.
    Brochu M; Bélanger A; Tremblay RR
    Fertil Steril; 1987 Dec; 48(6):948-53. PubMed ID: 2960564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate dependency of C19 conjugates in hirsute hyperandrogenic women and the influence of adrenal androgen.
    Carmina E; Gentzschein E; Stanczyk FZ; Lobo RA
    Hum Reprod; 1995 Feb; 10(2):299-303. PubMed ID: 7769052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
    O'Brien RC; Cooper ME; Murray RM; Seeman E; Thomas AK; Jerums G
    J Clin Endocrinol Metab; 1991 May; 72(5):1008-13. PubMed ID: 1827125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone is an effective and well tolerated systemic antiandrogen therapy for Hirsute women.
    Barth JH; Cherry CA; Wojnarowska F; Dawber RP
    J Clin Endocrinol Metab; 1989 May; 68(5):966-70. PubMed ID: 2715294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.